Jason Duncan Albireo Pharma, Inc. (ALBO) insider trading activity

Jason Duncan is Chief Legal Officer and GC of ALBIREO PHARMA, INC.. Currently has a direct ownership of 0 shares of ALBO, which is worth approximately $0. The most recent transaction as insider was on Mar 02, 2023, when has been sold 3,296 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Jason Duncan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 02 2023	SELL Disposition due to a tender of shares in a change of control transaction	-	3,296 Reduced 100.0%	0 Common Stock
Jan 23 2023	SELL Open market or private sale	$9,986 $43.8 p/Share	228 Reduced 1.59%	14,146 Common Stock
Jan 19 2023	SELL Open market or private sale	$41,178 $43.9 p/Share	938 Reduced 6.13%	14,374 Common Stock
Jan 19 2023	BUY Grant, award, or other acquisition	-	55,000 Added 44.3%	69,146 Common Stock
Oct 24 2022	SELL Open market or private sale	$12,799 $19.51 p/Share	656 Reduced 4.21%	14,931 Common Stock
Jul 25 2022	SELL Open market or private sale	$7,521 $24.03 p/Share	313 Reduced 1.97%	15,587 Common Stock
Jul 22 2022	SELL Open market or private sale	$8,452 $24.57 p/Share	344 Reduced 2.12%	15,900 Common Stock
Apr 25 2022	SELL Open market or private sale	$10,427 $33.42 p/Share	312 Reduced 1.91%	16,008 Common Stock
Apr 22 2022	SELL Open market or private sale	$11,319 $33.0 p/Share	343 Reduced 2.06%	16,320 Common Stock
Jan 24 2022	SELL Open market or private sale	$42,149 $24.97 p/Share	1,688 Reduced 9.2%	16,663 Common Stock
Jan 18 2022	BUY Grant, award, or other acquisition	-	10,800 Added 37.05%	18,351 Common Stock
Oct 25 2021	SELL Open market or private sale	$6,339 $29.21 p/Share	217 Reduced 2.87%	7,355 Common Stock
Oct 22 2021	SELL Open market or private sale	$2,741 $28.85 p/Share	95 Reduced 1.24%	7,572 Common Stock
Jul 23 2021	SELL Open market or private sale	$7,009 $31.43 p/Share	223 Reduced 2.83%	7,667 Common Stock
Jul 22 2021	SELL Open market or private sale	$3,072 $34.13 p/Share	90 Reduced 1.13%	7,890 Common Stock
Jun 25 2021	SELL Open market or private sale	$228,186 $36.22 p/Share	6,300 Reduced 44.12%	7,980 Common Stock
Jun 25 2021	BUY Exercise of conversion of derivative security	$155,421 $24.67 p/Share	6,300 Added 30.61%	14,280 Common Stock
Jun 24 2021	SELL Open market or private sale	$363,800 $36.38 p/Share	10,000 Reduced 55.62%	7,980 Common Stock
Jun 24 2021	BUY Exercise of conversion of derivative security	$243,600 $24.36 p/Share	10,000 Added 35.74%	17,980 Common Stock
Apr 23 2021	SELL Open market or private sale	$7,175 $32.32 p/Share	222 Reduced 2.75%	7,849 Common Stock
Apr 22 2021	SELL Open market or private sale	$2,858 $31.75 p/Share	90 Reduced 1.1%	8,071 Common Stock
Apr 01 2021	SELL Open market or private sale	$10,848 $36.16 p/Share	300 Reduced 3.55%	8,161 Common Stock
Apr 01 2021	BUY Exercise of conversion of derivative security	$7,212 $24.04 p/Share	300 Added 3.42%	8,461 Common Stock
Mar 31 2021	SELL Open market or private sale	$49,967 $35.04 p/Share	1,426 Reduced 14.87%	8,161 Common Stock
Jan 22 2021	SELL Open market or private sale	$3,808 $34.62 p/Share	110 Reduced 1.17%	9,332 Common Stock

Also insider at

NMRA

Neumora Therapeutics, Inc.

Chief Legal Officer

Jason Duncan

Chief Legal Officer and GC

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALBO shares.

Notify only if

Value

Insider Trading

Get notified when an Albireo Pharma, Inc. insider buys or sells ALBO shares.

Notify only if

Operation

Value

Type

News

Receive news related to ALBIREO PHARMA, INC.

Track Activities on ALBO

Account